Search Results

CNNC Atom High-Tech Sodium Iodide Capsules Supplied Directly to Macao for the First Time

Recently, sodium iodide [¹³¹I] capsules independently developed and produced by Atom High-Tech Co., Ltd., a subsidiary of China Isotope & Radiation Corporation under CNNC, successfully arrived at clinical frontlines in Macao, achieving the first stable supply of domestically produced sodium iodide [¹³¹I] capsules to Macao and completely filling the previous gap in Macao's lack of this clinical diagnostic and therapeutic service. It is understood that sodium iodide [¹³¹I] capsules are core radiopharmaceuticals widely used clinically for the diagnosis and treatment of thyroid diseases. Previously, Atom High-Tech had successfully achieved routine supply of short-half-life radiopharmaceuticals to Macao; the successful launch of this new product will strongly support Macao medical institutions in carrying out systematic radionuclide therapy and effectively reduce the burden of cross-border medical treatment on local patients.

2026-11-02

CGN Nuclear Technology Returns to the European Association of Nuclear Medicine Annual Congress, Hejia Isotopes Debut on the Global Nuclear Medicine Stage

The 39th Annual Congress of the European Association of Nuclear Medicine was held in Vienna, Austria, from October 17 to 21. CGN Nuclear Technology appeared once again, continuing its participation since its first exhibition in 2025, and showcased the core medical isotope products of CGN Isotope (Mianyang) Technology Co., Ltd. The exhibition focused on CGN Hejia® Germanium-68 solution, Germanium-Gallium generator and supporting automatic elution device, while also introducing multiple medical isotope products such as Oxygen-18, Copper-64, Zirconium-89 and Iodine-123. At this annual congress, physical exhibits such as the Germanium-Gallium generator and the supporting automatic elution device clearly demonstrated the company's technical...

2026-10-23

European Nuclear Medicine Congress Focuses on PET Nuclear Technology: Where Is the Boundary of Early Diagnosis

On October 19, 2026, at the plenary session of the European Association of Nuclear Medicine Congress (EANM 2026) held in Vienna, Austria, Professor Paola Anna Erba, President of the European Association of Nuclear Medicine, raised the major issue of when prevention is early enough. The conference held in-depth discussions on whether positron emission tomography (PET), a core nuclear medicine imaging technology, can detect cancer, cardiovascular disease, and Alzheimer's disease before symptoms appear. Regarding PET-based cancer screening in asymptomatic populations, Dr. Ken Herrmann of the University Hospital Essen in Germany clearly stated that currently, promoting fluorodeoxyglucose (FDG-PET)-based cancer screening in the general population is premature.

2026-10-20

Swiss Nuclear Forum Establishes Dedicated Nuclear Medicine Section to Help Optimize Regulatory Framework and Enhance Isotope Supply Security

Recently, the Swiss Nuclear Forum officially announced the establishment of a dedicated Nuclear Medicine Section, aimed at bringing together professional representatives from the pharmaceutical, medical, and scientific fields to jointly improve the framework conditions for nuclear medicine diagnosis and treatment in Switzerland, strengthen the stable supply of radionuclides, and accelerate the clinical application of innovative medical procedures. The Section is established under the Swiss Nuclear Forum, headquartered in Olten, and will take over and continue the relevant work of the former Swiss Alliance for Innovation in Nuclear Medicine, and will position itself...

2026-10-15

IAEA Hosts Global Dosimetry Symposium in Vienna: Focusing on Frontiers of Precision Radiation Medicine and Metrological Quality Control

From 5 to 9 October 2026, the International Symposium on Standards, Applications and Quality Assurance (IDOS 2026), hosted by the International Atomic Energy Agency (IAEA), was held at IAEA Headquarters in Vienna, Austria. More than 500 medical physicists, radiation metrology experts and researchers from 120 countries around the world gathered to discuss precision measurement of radiation doses in radiotherapy, medical imaging and nuclear medicine. With the rapid evolution of radiotherapy technologies, radionuclide therapy and interventional radiology, ionizing radiation in the diagnosis and treatment of malignant tumors and major diseases...

2026-10-08

Department of Nuclear Medicine at Peking University First Hospital Receives EARL Theranostics Advanced-L2 Certification, Bringing Theranostics in Line with International Standards

The Department of Nuclear Medicine at Peking University First Hospital has recently officially received the Theranostics Advanced-L2 certification issued by EARL (EANM Research Ltd.), an affiliate of the European Association of Nuclear Medicine, becoming one of the few nuclear medicine theranostics centers in China to obtain this high-level certification. The certification audit standards are rigorous, covering comprehensive dimensions including PET/CT quantitative accuracy, therapy center operations, patient safety management, and clinical competency. Passing the certification means that the department's quantitative imaging and targeted therapy data meet internationally mutually recognized standards and can achieve high-level alignment with advanced nuclear medicine centers in Europe and the United States. During the certification review, EANM President-Elect Professor Felix M. Mottaghy and Ms. Iva...

2026-10-03

Rosatom RDS presented domestic high-end medical equipment in Perm to accelerate regional healthcare import substitution

On September 25, 2026, the Second International Conference "Bioethics – A Panoramic View of the Future" (Биоэтика – панорамный взгляд в будущее) successfully concluded in Perm, Russia. Rosatom RDS JSC (АО «Росатом РДС»), the industry integration platform under the Russian State Atomic Energy Corporation (Rosatom) responsible for instruments and electronic equipment manufacturing, participated deeply in this event. During the special seminar on "Ethical Considerations of the Peaceful Use of Atomic Energy in Medicine" held as part of the conference, Rosatom RDS representatives...

2026-09-27

Sichuan Advances Cluster-Based Breakthroughs in Nuclear Medicine, Leveraging "One Chain, Four Poles" to Accelerate Clinical Translation and Deployment

At the 2026 Nuclear Technology Application and Nuclear Medicine Industry Innovation Development Conference held in Mianyang, Sichuan, participants focused on the strategic emerging industry track of deep integration between nuclear technology and modern medicine. As a key vehicle for developing new quality productive forces, Sichuan's nuclear medicine industry, relying on its long-accumulated advantages in scientific research and reactor irradiation resources, continues to expand in scale; according to the China Isotope & Radiation Association, Sichuan's nuclear medicine output value is projected to surpass the 10 billion yuan mark in 2026. In the fields of basic raw materials and therapeutic equipment, Sichuan possesses outstanding advantages in resource security and manufacturing concentration. More than 80% of the nation's medical isotopes rely on reactor irradiation for production, and the relevant reactors currently owned by Sichuan...

2026-09-24

The Nuclear Medicine Full-Chain High-Quality Development Empowerment Training Program Was Successfully Held in Mianyang, Sichuan

From September 6 to 11, the Nuclear Medicine Full-Chain High-Quality Development Empowerment Training Program, hosted by the Department of Human Resources and Social Security of Sichuan Province and organized by Mianyang Central Hospital, was successfully held in Mianyang, Sichuan. Hundreds of nuclear medicine peers from all over the country, including Beijing, Shanghai, Guangzhou, Tianjin, Chongqing, and Chengdu, completed all course studies and returned to their posts fully loaded with training results. This training was hosted by the Department of Human Resources and Social Security of Sichuan Province, organized by Mianyang Central Hospital, and co-organized by multiple departments including the Mianyang Municipal Human Resources and Social Security Bureau and the Fourth Division of Science and Technology Innovation and Industrial Innovation Integration Development of Mianyang Science and Technology City. The training content focused on nuclear medicine from laboratory research and development to clinical application...

2026-09-14

Rosatom Proposes to Offer India Large-Capacity Nuclear Power and SMR Solutions

On September 10, the State Atomic Energy Corporation Rosatom (Rosatom) stated that it is ready to provide India with a range of nuclear energy solutions, covering large-capacity nuclear power units and small modular reactors. Kirill Komarov, First Deputy Director General and Director of the Development and International Business Department of Rosatom, said during the India Industrial Development Forum (Innoprom.India) held in New Delhi that, considering the scale of relevant projects in India, Rosatom can provide partners with modern nuclear energy solutions, including both large nuclear power plants and small nuclear power plant technology routes. Ko...

2026-09-11

Best Cyclotron Systems 70MeV high-current proton cyclotron passes factory acceptance test, to be delivered to Taiwan, China

Best Cyclotron Systems (BCS) recently announced that its 70 megaelectronvolt (MeV) high-current proton cyclotron B-70 completed factory acceptance testing in July, and the equipment will soon be delivered to the National Atomic Research Institute (NARI) in Taoyuan City, Taiwan, China. Related installation and project construction are expected to be completed in 2027. According to the introduction, B-70 was designed, developed and manufactured in Canada by engineers and scientists under TeamBest, and is an advanced cyclotron system for high-current proton beam applications. The equipment will be used to expand accelerator-based radioisotope production and research capabilities, and also reflects the company's...

2026-09-11

Denmark's Region East Denmark to expand Sectra One imaging platform, unifying regional nuclear medicine and other medical imaging services

Swedish medical imaging IT and cybersecurity company Sectra has recently signed a contract to expand the application of its Sectra One enterprise imaging solution from hospitals in Denmark's Capital Region to the entire Region East Denmark. Region East Denmark was formed by merging the Capital Region and Region Zealand, and this expansion aims to promote unified operation of imaging services across hospitals in the entire region. Under the contract, Sectra One will be delivered as a fully managed cloud service, covering all hospitals in Region East Denmark for the review and storage of radiology medical images, including breast imaging, nuclear medicine, and clinical physiology. Hospitals in Region Zealand will migrate to the system currently in use in the Capital Region,...

2026-09-11

Canada Supports IAEA "Rays of Hope" Initiative for the First Time, Will Provide Medical Isotope Training for Latin America

The Canadian Nuclear Isotope Council (CNIC) announced on September 10 that Canada has for the first time formally provided support to the International Atomic Energy Agency (IAEA) Rays of Hope initiative, and will help enhance cancer diagnosis and treatment capacity in Latin America through training in the production of medical radioisotopes and radiopharmaceuticals. The Rays of Hope initiative aims to expand access to cancer treatment and radiotherapy infrastructure in low- and middle-income countries. Under the arrangement, from November 8 to 14, 26 relevant sector leaders from Argentina, Brazil, Chile and Mexico will travel to Ontario, Canada, to participate in a training program jointly organized by Bruce Power and McMaster University. The training will focus on medical isotopes...

2026-09-11

Rapid Arc Dynamic Precision Radiotherapy Technology Launched in Western New South Wales, Australia

Cancer patients in western New South Wales, Australia, have recently gained a new radiotherapy option. The Western New South Wales Local Health District has introduced Rapid Arc Dynamic (RAD) technology at the Western Cancer Centre at Dubbo Health Service, becoming the first public health institution in Australia to offer this service. According to reports, RAD is a highly precise and personalized radiotherapy technology that can help clinicians more accurately target tumor areas while minimizing radiation exposure to surrounding healthy tissue. This technology is suitable for a variety of treatment scenarios, particularly for patients with longer tumor extents and lymph node metastases. R...

2026-09-10

Siemens Healthineers Completes PET Detector Manufacturing Expansion Project in Tennessee, USA

Siemens Healthineers recently completed the expansion and renovation project of its PET detector center in Rockford, Tennessee, USA, with a total investment of $43.6 million. The project aims to enhance PET detector manufacturing capacity to meet the growing demand for PET/CT scanning equipment. The project added 40,000 square feet of building area to the existing 97,000-square-foot campus and renovated 7,500 square feet of existing space. The Rockford facility is Siemens Healthineers' only manufacturing site globally for producing PET detectors used in its PET/CT systems. The expansion includes 36,000 square feet of dedicated manufacturing space and a 4,000-square-foot expansion of R&D facilities; meanwhile, the company also renovated...

2026-09-10